Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
Cash Flows From Operating Activities | |||||
Net Income | -1,481 | -56,065 | -77,041 | -55,910 | -41,806 |
Depreciation Amortization | 5,036 | 5,005 | 4,535 | 3,136 | 2,677 |
Accounts receivable | N/A | N/A | N/A | -12,055 | 35 |
Accounts payable and accrued liabilities | 76 | -2,223 | -278 | -727 | 3,009 |
Other Working Capital | 4,072 | -17,210 | 12,326 | 13,538 | 5,281 |
Other Operating Activity | 889 | 17,345 | 5,387 | 16,190 | -2,519 |
Operating Cash Flow | $8,592 | $-53,148 | $-55,071 | $-35,828 | $-33,323 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -21,489 | 21,335 | 45,349 | -895 | -52,891 |
PPE Investments | -9,149 | -1,189 | -2,707 | -19,059 | -8,067 |
Other Investing Activity | 0 | 0 | 204 | 0 | -400 |
Investing Cash Flow | $-30,638 | $20,146 | $42,846 | $-19,954 | $-61,358 |
Cash Flows From Financing Activities | |||||
Debt Issued | 14,806 | N/A | N/A | 5,814 | 3,997 |
Debt Repayment | -2,088 | -4,139 | -4,249 | -3,546 | -2,235 |
Common Stock Issued | 17,049 | 19,673 | 11,173 | 67,819 | 45,993 |
Other Financing Activity | -7,500 | 4,882 | 0 | 0 | 47,171 |
Financing Cash Flow | $22,267 | $20,416 | $6,924 | $70,087 | $94,926 |
Beginning Cash Position | 13,450 | 26,036 | 31,337 | 17,032 | 16,787 |
End Cash Position | 13,671 | 13,450 | 26,036 | 31,337 | 17,032 |
Net Cash Flow | $221 | $-12,586 | $-5,301 | $14,305 | $245 |
Free Cash Flow | |||||
Operating Cash Flow | 8,592 | -53,148 | -55,071 | -35,828 | -33,323 |
Capital Expenditure | -9,178 | -1,189 | -2,732 | -19,059 | -8,067 |
Free Cash Flow | -586 | -54,337 | -57,803 | -54,887 | -41,390 |